Literature DB >> 10191815

Directly observed therapy and tuberculosis treatment completion. Bloch re: Bayer et al.

A B Bloch.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10191815      PMCID： PMC1508871          DOI： 10.2105/ajph.89.4.602

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  4 in total

1.  Eleven years of community-based directly observed therapy for tuberculosis.

Authors:  C P Chaulk; K Moore-Rice; R Rizzo; R E Chaisson
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

2.  Directly observed therapy and treatment completion for tuberculosis in the United States: is universal supervised therapy necessary?

Authors:  R Bayer; C Stayton; M Desvarieux; C Healton; S Landesman; W Y Tsai
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

3.  Preventing multidrug-resistant tuberculosis.

Authors:  A B Bloch; P M Simone; E McCray; K G Castro
Journal:  JAMA       Date:  1996-02-14       Impact factor: 56.272

4.  The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis.

Authors:  S E Weis; P C Slocum; F X Blais; B King; M Nunn; G B Matney; E Gomez; B H Foresman
Journal:  N Engl J Med       Date:  1994-04-28       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.